Option chain shows key data for Novaccess Global's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Novaccess Global.

Novaccess Global (OTC:XSNX) Stock, Option Chain

Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.

Long Ideas

News

Penny Stocks

Small Cap

Insider Trades

Trading Ideas

IDEX

TCON

XSNX

The IHS Markit composite PMI dipped to 50.8 in January 2022 from 57.0 a month ago, according to data released today. However, investors also focused on some insider trades in penny stocks.

4 Penny Stocks Insiders Are Buying: Ideanomics, Superior Industries And More

Intraday Update

Markets

Movers

AAVMY

ABLT

ACSAF

ACWRF

AGEEF

APRN

ARLP

ATIS

AWSM

AXDDF

BLUU

BSAC

BTTR

BWSOF

CJPRY

CTHR

CULP

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CWBHF

DIFTY

DIIBF

DKDRF

DLUEY

DNOW

DNTUY

ECOL

ENBL

EXMT

FLMMF

FOSL

GFGSF

GGXXF

GLOP

GNMK

GRCO

GRPN

GSUM

GWRRF

HBRM

HNRG

IMAC

INAR

ITOX

JAPSY

KGAUF

KNCAF

KRKR

KRNY

LFDEF

MAYNF

MCUJF

MITO

NAKD

NEPT

NEVPF

NSANY

NXNN

OWRDF

PCLOF

PHOT

PLYZ

PRED

RDS-B

ROYMY

RSSV

RIGHT ON BRANDS INC by Right On Brands, Inc.

RTON

SCIE

SHRG

SOLCF

SOMMY

SRLP

TACYY

TBLMY

TCHH

TMDI

TRNX

TRYIY

Stocks That Hit 52-Week Lows On Wednesday

NOVACCESS GLOBAL INC by NOVACCESS GLOBAL INC.

Novaccess Global Inc

The IHS Markit composite PMI dipped to 50.8 in January 2022 from 57.0 a month ago, according to data released today. However, investors also focused on some insider trades in penny stocks.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Superior Industries </h2>
<ul>
<li>The Trade: Superior Industries International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sup#NYSE">SUP</a>) 10% owner Thomas Lynch <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 40632 shares </a> at an average price of $4.26. To acquire these shares, it cost 173.23 thousand.</li>
<li>What&rsquo;s Happening: The company&rsquo;s shares dropped 7% over the previous month.</li>
<li>What Superior Industries Does: Superior Industries International Inc is a manufacturer of aluminum wheels for passenger automobiles and light-duty vehicles.</li>
</ul>
<h2>TRACON Pharmaceuticals </h2>
<ul>
<li>The Trade: TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) 10% owner Opaleye Management Inc <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 45000 shares </a> at an average price of $2.25. The insider spent $101.03 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company, last month, announced results from the Independent Data Monitoring Committee review of interim safety and efficacy data from the ongoing ENVASARC pivotal trial.</li>
<li>What TRACON Pharmaceuticals Does: TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.</li>
</ul>
<h2>Ideanomics </h2>
<ul>
<li>The Trade: Ideanomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idex#NASDAQ">IDEX</a>) CEO Alfred Poor <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 14500 shares </a> at an average price of $1.07. To acquire these shares, it cost $15.52 thousand.</li>
<li>What&rsquo;s Happening: Ideanomics recently made a strategic investment in InoBat Auto, a European-based premium battery technology and manufacturing company.</li>
<li>What Ideanomics Does: Ideanomics Inc is a global company that facilitates the adoption of commercial electric vehicles and supports next-generation financial services and Fintech products.</li>
</ul>
<h2>NovAccess Global </h2>
<ul>
<li>The Trade: NovAccess Global Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/xsnx#OTC">XSNX</a>) Chief Financial Officer Neil J Laird <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 250000 shares </a> at an average price of $0.20. The insider spent $50 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s shares dropped around 20% over the past month.</li>
<li>What NovAccess Global Does: Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States.</li>
</ul>

Comments

Novaccess Global

Novaccess Global (XSNX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga